These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16929354

  • 1. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R, Bergami A, Brambilla E, Butti E, De Simoni MG, Campagnoli M, Marconi P, Comi G, Martino G.
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [Abstract] [Full Text] [Related]

  • 2. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 3. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC, Lalor SJ, Lynch MA, Mills KH.
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages.
    van Strien ME, Mercier D, Drukarch B, Brevé JJ, Poole S, Binnekade R, Bol JG, Blits B, Verhaagen J, van Dam AM.
    Gene Ther; 2010 May; 17(5):662-71. PubMed ID: 20182518
    [Abstract] [Full Text] [Related]

  • 5. Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.
    Nygårdas M, Aspelin C, Paavilainen H, Röyttä M, Waris M, Hukkanen V.
    Gene Ther; 2011 Jul; 18(7):646-55. PubMed ID: 21326329
    [Abstract] [Full Text] [Related]

  • 6. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB, Horton JL, Chen Y.
    Cell Immunol; 1998 Sep 15; 188(2):118-24. PubMed ID: 9756642
    [Abstract] [Full Text] [Related]

  • 7. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T.
    J Immunol; 1995 Jan 15; 154(2):944-53. PubMed ID: 7814894
    [Abstract] [Full Text] [Related]

  • 8. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN, Zhong XG, Feng JQ, Yang YF, Fu YF, Ni J, Liu QF, Tang W, Zhao WM, Zuo JP.
    J Pharmacol Exp Ther; 2006 Sep 15; 318(3):1153-62. PubMed ID: 16751252
    [Abstract] [Full Text] [Related]

  • 9. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
    Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Wekerle H.
    Eur J Immunol; 1993 Jun 15; 23(6):1364-72. PubMed ID: 7684687
    [Abstract] [Full Text] [Related]

  • 10. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X, Qin X.
    Int J Mol Med; 2013 May 15; 31(5):1209-21. PubMed ID: 23525227
    [Abstract] [Full Text] [Related]

  • 11. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
    Furlan R, Poliani PL, Galbiati F, Bergami A, Grimaldi LM, Comi G, Adorini L, Martino G.
    Hum Gene Ther; 1998 Nov 20; 9(17):2605-17. PubMed ID: 9853527
    [Abstract] [Full Text] [Related]

  • 12. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
    Wheeler RD, Zehntner SP, Kelly LM, Bourbonnière L, Owens T.
    Immunology; 2006 Aug 20; 118(4):527-38. PubMed ID: 16780563
    [Abstract] [Full Text] [Related]

  • 13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

  • 14. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML, Owens T.
    Eur J Immunol; 1997 Nov 01; 27(11):2840-7. PubMed ID: 9394808
    [Abstract] [Full Text] [Related]

  • 15. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
    Cohen SJ, Cohen IR, Nussbaum G.
    J Immunol; 2010 Jan 01; 184(1):212-21. PubMed ID: 19949074
    [Abstract] [Full Text] [Related]

  • 16. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
    Broberg E, Setälä N, Röyttä M, Salmi A, Erälinna JP, He B, Roizman B, Hukkanen V.
    Gene Ther; 2001 May 01; 8(10):769-77. PubMed ID: 11420640
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
    Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, Franciotta DM, Penna G, Comi G, Adorini L, Martino G.
    J Immunol; 2001 Aug 01; 167(3):1821-9. PubMed ID: 11466408
    [Abstract] [Full Text] [Related]

  • 18. Murine complement C4 is not required for experimental autoimmune encephalomyelitis.
    Boos LA, Szalai AJ, Barnum SR.
    Glia; 2005 Jan 01; 49(1):158-60. PubMed ID: 15390104
    [Abstract] [Full Text] [Related]

  • 19. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M, Ardesjö B, Rönnblom L, Kämpe O, Lassmann H, Eloranta ML, Lobell A.
    Eur J Immunol; 2009 Oct 01; 39(10):2925-35. PubMed ID: 19637225
    [Abstract] [Full Text] [Related]

  • 20. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
    Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, Glorioso JC, Comi G, Martino G.
    Gene Ther; 2001 Jan 01; 8(1):13-9. PubMed ID: 11402297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.